000 05749nam a22003495i 4500
999 _c76864
_d76864
_x1
001 76864
003 ES-MaUEC
005 20230207040242.0
007 cr nn 008mamaa
008 131021s2014 ne | s |||| 0|eng d
020 _a9789400773295
024 7 _a10.1007/978-94-007-7329-5
_2doi
040 _dES-MaUEC
050 4 _aQH588.S83
_bH393 2014
100 1 _aHayat, M. A.
_eeditor literario
_0Local
_986068
245 1 0 _aStem Cells and Cancer Stem Cells, Volume 11 :
_bTherapeutic Applications in Disease and injury
_cedited by M.A. Hayat.
260 _aDordrecht, Netherlands
_bSpringer International Publishing
_c2014
300 _a1 recurso en línea (XXXVIII, 280 p.)
_b26 ilustraciones, 18 ilustraciones en color
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
490 0 _aStem Cells and Cancer Stem Cells
_x2215-0994
_v11
505 0 _aPreface. I. Embryonic stem cells -- Maintenance of human embryonic stem cell identity and Inhibition of extraembryonic differentiation: Role of cnot1, cnot2 and cnot3.-Investigating the role of the embryonic stem cell self-renewal gene nanog in neoplastic processes -- Derivation and expansion of human embryonic stem cells under xeno-free, defined conditions -- Self-renewal of naÃv̄e state mouse embryonic stem cells: Role of lacdinac in lif/stat3 signaling -- Cancer gene therapy potential of neural stem cells derived from human embryonic stem cells and induced pluripotent stem cells. II. Cancer stem cells -- The role of cancer stem(-like) cells and epithelial-to-mesenchymal transition in spreading head and neck squamous cell carcinoma -- Glioma propagating cells show enhanced chemoresistance and radioresistance (an update) -- Chemical genomic approaches to eradicate leukemia stem cells -- Isolation of cancer stem cells showing drug resistance in the human epithelia ovarian cancer -- Cancer stem cells in pediatric sarcomas -- Cancer stem cells derived from mouse induced pluripotent stem cells -- Stemness regulation of somatic cancer cells -- Induced differentiation of brain tumour stem cells -- Role of microenvironment in regulating stem cell and tumor initiating cancer cell behavior and its potential therapeutic implications -- Identification of ovarian cancer stem cells: molecular pathways. III. Hematopoietic stem cells -- Hematopoietic stem cells and bone regeneration -- Children with solid tumors: identification of ematopoietic and endothelial progenitor cells as biomarkers -- Pediatric neuroblastoma: combined treatment with monoclonal antibody and cytokines preceded by matopoietic stem cell transplantation -- Autologous and allogeneic hematopoieitic cell transplantation: risk of second malignancies. IV. Neural stem cells -- Treatment of injured spinal cord: engraftment of neural stem cells -- Spinal cord injury ngineering using neural stem cells -- Endogenous regenerative potential of neural stem/progenitor cells of the newborn brain (an overview).Index.
520 _aVolume 11 in this series discusses therapeutic applications of stem cells in disease and tissue injury. Coverage includes pluripotent stem cells, which can give rise to the endodermal, ectodermal, and mesodermal lineages; multipotent stem cells, which can generate all cells in a particular lineage and unipotent stem cells, which can give rise to only one cell type. This volume also examines cancer stem cells, tumor-initiating cells which possesses the capacity of self-renewal and can give rise to the heterogeneous lineages of cancer cells that comprise the tumor. Coverage extends to molecular mechanisms underlying the derivation and expansion of human embryonic stem cells, the role of specific proteins in the maintenance and inhibition of extraembryonic differentiation of these cells and the role of signaling responsible for the self-renewal of mouse embryonic stem cells. Nine chapters discuss the clinical importance of cancer stem cells, encompassing glioma, leukemia, ovarian cancer, pediatric sarcomas and head and neck squamous cell carcinoma. The role of cancer stem cells is also elucidated in epithelial-to-mesenchymal transition in spreading head and neck squamous cell carcinoma. The book goes on to survey therapeutic application of stem cells of hematopoietic and non-hematopoietic origin for regeneration of bones, including in osteoporotic bone disease; to illuminate the application of hematopoietic stem cells in bone regeneration and to discuss their use as a biomarker to facilitate determination of a treatment. The contributors review cells as biomarkers for pediatric solid tumors, and weigh the advantages and limitations of hematopoietic stem cell transplantation. Also included are details of neural stem cell engraftment in the injured spinal cord; the regenerative potential of neural stem/progenitor cells of newborns and cancer gene therapy potential using neural stem cells. Like the preceding volumes in the series, this book is distinguished for its comprehensive approach, its distinguished roster of 58 contributors representing 10 different countries and its thorough review of leading-edge technology and methods.
650 7 _2embne
_aCélulas madre
_9160528
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-94-007-7329-5
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907 _a.b12824823
_b10-10-17
_c01-10-14
942 _2lcc
_cLE
945 _aQH588.S83 H393 2014 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11554034
_z06-04-17
988 _aEBSPRINGER
998 _am
_a_alco
_a_vill
_b - -
_cm
_dz
_e-
_feng
_gne
_h0